Compare GNE & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNE | CYRX |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.1M | 419.3M |
| IPO Year | 2011 | 2008 |
| Metric | GNE | CYRX |
|---|---|---|
| Price | $14.06 | $8.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 45.7K | ★ 398.4K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | 0.76 | ★ 1.40 |
| Revenue | ★ $425,202,000.00 | $176,177,000.00 |
| Revenue This Year | $17.49 | $11.06 |
| Revenue Next Year | $7.07 | $8.45 |
| P/E Ratio | $18.59 | ★ $6.26 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.27 | $4.63 |
| 52 Week High | $28.47 | $11.45 |
| Indicator | GNE | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 57.90 |
| Support Level | $13.53 | $8.01 |
| Resistance Level | $14.87 | $9.32 |
| Average True Range (ATR) | 0.55 | 0.42 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 46.25 | 97.80 |
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.